API manufacturers address critical medicines shortages leaving Europeans and Americans vulnerable and dependent on Asian supplies

EFCG – BPTF Press release 12/02/2020

Active Pharmaceutical Ingredients (API) manufacturers express their concerns and urge EU and US authorities for action as the Coronavirus outbreak in China further highlights the vulnerability of the pharmaceutical supply chain.  read more



EU and US reach a milestone in mutual recognition of inspections of medicines manufacturers

EMA Press release 12/07/2019

With the recognition by the US Food and Drug Administration (FDA) of Slovakia, the European Union and the United States have now fully implemented the mutual recognition agreement (MRA) for inspections of manufacturing sites for certain human medicines in their respective territories.

read more


EU Council adopts SPC waiver text voted in EP in April

The Council of the EU adopted on 14th May the SPC waiver text that was voted in the EU Parliament in April. The regulation, approved during the Agriculture and Fisheries Council meeting, still needs to be published in the Official Journal, and is expected to enter into force on July 1, 2019. The waiver affects all SPCs applied for after the regulation enters into force and the text adds that “…the exception should apply, therefore, from 1 July 2022 to a certificate that takes effect from the date of entry into force of this Regulation”.

read more


Commission presents Strategic Approach to Pharmaceuticals in the Environment

The European Commission has adopted a Communication outlining a set of actions addressing the “Strategic Approach to Pharmaceuticals in the Environment”. The plan that the Commission presented on March 11th, identifies six action areas concerning all stages of the pharmaceutical life cycle, where improvements can be made.

read more


EU Health Summit – Recommendations for a healthier Europe

EFCG is a proud member of the coalition of associations behind the high-level EU health Summit that took place last November 29th in Brussels. This multi-stakeholder event, …

read more

EMA Booklet – From lab to patient

 EMA has published a booklet describing the journey of a medicine for human use authorised through EMA, from initial research to discussions on patient access to medicines across the EU: From laboratory to patient: the journey of a centrally authorised medicine – Link.

SPC manufacturing waiver

On January 23rd, 2019, the European Parliament’s JURI Committee voted its amendments to the Commission’s proposal amending Regulation (EC 469/2009) concerning the supplementary protection certificate for medicinal products. For more information, download our briefing note. Download.